A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle Lapidus(Icahn School of Medicine at Mount Sinai), Cara F. Levitch(Icahn School of Medicine at Mount Sinai), Andrew M. Perez(Icahn School of Medicine at Mount Sinai), Jess W. Brallier(Icahn School of Medicine at Mount Sinai), Michael K. Parides(Icahn School of Medicine at Mount Sinai), Laili Soleimani(Icahn School of Medicine at Mount Sinai), Adriana Feder(Icahn School of Medicine at Mount Sinai), Dan V. Iosifescu(Allen Institute for Brain Science), Dennis S. Charney(Icahn School of Medicine at Mount Sinai), James W. Murrough(Allen Institute for Brain Science)
Cited by 480Open Access